Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin

Travel Med Infect Dis. 2021 Jan-Feb:39:101954. doi: 10.1016/j.tmaid.2020.101954. Epub 2020 Dec 13.
No abstract available

Publication types

  • Comment

MeSH terms

  • Azithromycin / therapeutic use
  • COVID-19 Drug Treatment*
  • Drug Therapy, Combination
  • France
  • Humans
  • Hydroxychloroquine* / therapeutic use
  • Retrospective Studies
  • SARS-CoV-2

Substances

  • Hydroxychloroquine
  • Azithromycin